U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients

Documenti analoghi

• Delayed Response to U-500 Regular Insulin
  di: Davidson, Mayer B.
  Pubblicazione: (2018)
• Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
  di: de la Peña, Amparo, et al.
  Pubblicazione: (2011)
• Erratum: Delayed Response to U-500 Regular Insulin. Clinical Diabetes 2018;36: 77–79 (DOI: 10.2337/cd16-0058)
  di: Davidson, Mayer B.
  Pubblicazione: (2018)
• Duration and onset of action of high dose U‐500 regular insulin in severely insulin resistant subjects with type 2 diabetes
  di: Shrestha, Rupendra T., et al.
  Pubblicazione: (2018)
• Use of U-500 Regular Insulin via Continuous Subcutaneous Insulin Infusion: Clinical Practice Experience
  di: Reutrakul, Sirimon, et al.
  Pubblicazione: (2011)